Drug Profile
Hementin
Alternative Names: EMD 66777Latest Information Update: 23 Sep 1998
Price :
$50
*
At a glance
- Originator Biopharm (UK)
- Developer Biopharm (UK); Merck KGaA
- Class Anticoagulants
- Mechanism of Action Fibrinogen receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 23 Sep 1998 No-Development-Reported for Thrombosis in Germany (Unknown route)
- 23 Sep 1998 No-Development-Reported for Thrombosis in United Kingdom (Unknown route)
- 23 Sep 1998 No-Development-Reported for Thrombosis in USA (Unknown route)